Free Trial
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Price, News & Analysis

Calithera Biosciences logo
$0.0010 +0.00 (+400.00%)
As of 08/7/2025 12:28 PM Eastern

About Calithera Biosciences Stock (NASDAQ:CALA)

Key Stats

Today's Range
$0.0010
$0.0010
50-Day Range
N/A
52-Week Range
$0.00
$0.05
Volume
323 shs
Average Volume
10,439 shs
Market Capitalization
$4.87 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Calithera Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

CALA MarketRank™: 

Calithera Biosciences scored higher than 41% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Calithera Biosciences.

    • Percentage of Shares Shorted

      0.14% of the outstanding shares of Calithera Biosciences have been sold short.
    • Short Interest Ratio / Days to Cover

      Calithera Biosciences has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Calithera Biosciences has recently decreased by 64.95%, indicating that investor sentiment is improving significantly.
    • Dividend Yield

      Calithera Biosciences does not currently pay a dividend.

    • Dividend Growth

      Calithera Biosciences does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      0.14% of the outstanding shares of Calithera Biosciences have been sold short.
    • Short Interest Ratio / Days to Cover

      Calithera Biosciences has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Calithera Biosciences has recently decreased by 64.95%, indicating that investor sentiment is improving significantly.
    • MarketBeat Follows

      1 people have added Calithera Biosciences to their MarketBeat watchlist in the last 30 days.
    Receive CALA Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

    CALA Stock News Headlines

    Calithera Biosciences Inc (CALA)
    Is Elon's empire crumbling?
    The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
    Arcus Biosciences Inc (RCUS)
    Christina Cala
    CALA - Calithera Biosciences, Inc.
    See More Headlines

    CALA Stock Analysis - Frequently Asked Questions

    Calithera Biosciences' stock was trading at $0.0001 at the beginning of 2025. Since then, CALA stock has increased by 900.0% and is now trading at $0.0010.

    Calithera Biosciences, Inc. (NASDAQ:CALA) announced its quarterly earnings data on Monday, November, 8th. The biotechnology company reported ($3.00) EPS for the quarter, beating analysts' consensus estimates of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter.

    Calithera Biosciences's stock reverse split on the morning of Wednesday, June 15th 2022.The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

    Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX) and First Solar (FSLR).

    Company Calendar

    Last Earnings
    11/08/2021
    Today
    8/07/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:CALA
    CIK
    1496671
    Fax
    N/A
    Employees
    60
    Year Founded
    2010

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    N/A
    Price / Sales
    N/A
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    4,870,000
    Free Float
    4,550,000
    Market Cap
    $4.87 thousand
    Optionable
    Not Optionable
    Beta
    -2.77

    Social Links

    Reduce the Risk Cover

    Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

    Get This Free Report

    This page (NASDAQ:CALA) was last updated on 8/8/2025 by MarketBeat.com Staff
    From Our Partners